Gsk (GSK) Property, Plant & Equipment (Net) (2009 - 2026)

Gsk (GSK) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	23.58 Bn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	5.80 Bn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	25.74 Bn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	94.68 Bn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	87.87 Bn
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	8.55 Bn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	5.83 Bn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	19.03 Bn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	12.56 Bn
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	113.37 Bn

Download Data